At first glance, Reed would seem to be an unlikely incubator for medical research. Unattached to a medical school or nursing program, its focus on liberal arts and sciences might appear rather remote from the pressing issues of medicine. What does Aristophanes have to do with astrocytes? What does Plato say about peptides?
Turns out the answer is: plenty. In fact, approximately 1,242, or roughly 8%, of our alumni are employed in health care and hundreds more are directly involved in biomedical research. In this issue, we decided to highlight a small fraction of the amazing work that Reed and Reedies have produced in this field. From the mechanics of multiple sclerosis to the role of zinc to the development of cheaper anti-malarial drugs, you’ll find Reedies at the frontier of human knowledge, demonstrating (if any proof were needed) the vital link between the liberal arts and sciences and the healing arts and sciences.
Mary McMillan [reconstruction aide 1918–19] pioneered the use of physical therapy in the US and was the founding president of the Women's Physical Therapeutic Association (later the American Physiotherapy Association).
Renowned bacteriologist Calista Eliot Causey ’20 spent decades identifying deadly pathogens in the jungles of Brazil and Nigeria with her husband (and former student) Ottis. Discovered nearly 50 new viruses.
Flight surgeon Albert Schwichtenberg ’26 won two Legion of Merit Awards in WW II, directed the medical phase of the first astronaut selection program, and was one of the first doctors to grapple with overcoming the limits of the human body in space.
In 1942, Yale pharmacologist Louis Goodman ’28 showed that mustard gas—the dreaded WWI chemical weapon—could be used to treat lymphosarcoma, opening the door to the use of chemicals to fight cancer.
Naval surgeon Bud Zeller ’33 served on the battleship U.S.S. Tennessee in WWII, saw action at battles of Leyte Gulf and Surigao Strait, and pioneered the use of hypnosis for post-operative pain relief.
Stanford zoologist Jane Graybill Collier Anderson ’37 helped create the first polio vaccine, which later became the foundation for the Salk vaccine. Also carved totem poles.
Flight surgeon Julius Sue ’38 served with the Flying Tigers during WWII. After the war, he moved to Los Angeles, where he cared for veterans and immigrants, earning him the nickname “the Godfather of Chinatown.”
Pfizer biochemist Ken Koe ’45 took a closer look at a discarded molecule and reckoned that with slight modification it could inhibit reuptake of serotonin. Result? Zoloft.
Renowned cardiologist Hank Akiyama ’53 moved to Juneau, Alaska in 1969, and was at the scene of virtually every cardiac arrest that occurred in the city from 1969 until 1982.
Malaria researcher Michael Makler ’58 discovered novel enzyme markers which led to the invention of a portable, inexpensive microscopy instrumentation. With molecular physiologist Robert Piper ’85 developed the first cheap, simple, rapid test for drug-resistant malaria, which was field-tested through the work of Sam Martin ’72, top malaria investigator at the Walter Reed Army Institute of Research in Kenya.
Harvard biochemist (and ace violinist) Mark Ptashne ’61 originated “ball and stick” model of transcription factors and conducts research on the problem of how genes turn off and on.
Yale biophysicist Don Engelman ’62 performs research on how peptides can target—and destroy—tumors.
Robert Gelber ’63 is one of the world’s leading experts on Hansen’s Disease (aka leprosy) and has published more than 120 papers on the care and treatment of patients afflicted by this ancient and stigmatized illness.
Psychologist Susan Crawford Salasin ’64 was the victim of a violent crime at age 16. She went on to become an expert in trauma and now directs the Trauma and Trauma-Informed Care Program at SAMHSA.
Chemist and mountaineer Arlene Blum ’66 has led the charge against the use of carcinogenic flame-retardants in pyjamas, cushions, and furniture. Also led an all-women's team to the peak of Annapurna.
Geneticist Bruce Baker ’66 discovered the doublesex gene, which plays a key role in determining the sex of fruit flies, and has made important contributions to understanding the genetic basis of courtship behavior.
Computer scientist Richard Crandall ’69 devised fiendishly complex algorithms to predict the propagation of Asian flu—and other infectious diseases—using Census data.
Ophthalmologist Marc Lieberman ’70 founded the Tibet Vision Project, which trains Tibetan doctors to perform surgery to restore sight in the region’s remotest and most impoverished hinterlands.
In 1990, neurosurgeon Wise Young ’71 established the first effective therapy for spinal-cord injury, proving that such injury need not be irreversible. He is now a leader in the development of new therapies for spinal-cord injury and treated actor Christopher Reeve.
Former DARPA researcher Michael Goldblatt ’74 is developing drugs that combat influenza, respiratory viruses, and HIV through a process known as random homozygous gene perturbation.
Epidemiologist and mathematician Chris Amos ’80 identified genetic mutations that make some smokers more susceptible to lung cancer than others.
Roger Tung ’81 co-invented two key HIV protease inhibitors that became commercial drugs, Agenerase and Lexiva, plus various other compounds to treat hepatitis and cystic fibrosis. He is now working on compounds based on deuterium.
Both a sociologist and a statistician, Martina Morris ’80 invented a new model of HIV transmission in sub-Saharan Africa with dramatic implications for prevention
Chemist Rebecca Braslau ’81 developed a spray that makes urushiol—the toxic oil in poison ivy, poison oak, and poison sumac—glow in ultraviolet light. Disco parties are now mandatory for backpackers.
Genetic engineer Pamela Ronald ’82 has developed a strain of flood-resistant rice that could prevent famine in flood-prone areas of the globe.
Renowned neuroscientist Gina Turrigiano ’84 introduced the theory of “synaptic scaling” to explain how neural circuits adapt to changes in the brain.
A professor at UC Berkeley and UCSF, chemist Kevan Shokat ’86 pioneered the use of kinases, special enzymes that govern cellular activity, to attack cancer cells.
Regina Cugnini Dehen ’87 oversees clinical faculty at the Oregon College of Oriental Medicine, where she specializes in complementary and alternative medicine, reproductive health, and research.
Must allopathic and alternative medicine forever be in conflict? Lorenzo Cohen ’87 spearheads the use of acupuncture and yoga for cancer patients undergoing radiotherapy at the University of Texas M.D. Anderson Cancer Center.
UC Davis researcher Paul Knoepfler ’89 is probing the mystery of pluripotency (ie the ability of certain cells to develop into different kinds of cells) and why the machinery that controls it goes haywire in cancer.
Veterans Affairs otolaryngologist Erick Gallun ’94 researches the effects of aging, hearing loss, and traumatic brain injury on perception and cognition.
Physician Kinari Webb ’95 established a clinic in a remote area of Borneo where the destruction of rainforest threatens both the ecosystem and human health. Her clinic treats local villagers and helps them fight illegal logging.
Half-physicist, half-biologist, Jan Liphardt ’96 is a leader in the field of mechanobiology. His lab at UC Berkeley investigates how mechanical forces affect proteins, cells, and tissues, with profound implications for understanding cancer.
A chemical biologist at the Broad Institute, Angela Koehler ’97 investigates--with so-called “small-molecule probes”--how to disrupt the transcription factors that run amok in cancer cells.
Neal Miller ’97 is a leader in the field of applied behavior analysis, focusing on how to teach people with autism better skills in social interaction, communication, and play.
Many parts of Haiti suffer from poor sanitation and depleted soil. Sasha Kramer ’99 leads a non-profit that installs composting toilets that stop the spread of disease while producing fertilizer.
UCSF biochemist JJ Miranda ’01 probes the inner structure of viral genomes to understand better their role in causing cancer.
Kristie Miller Keeney ’01 studies the metabolic adaptation of bacterial pathogens at the University of British Columbia.
UCSF postdoc Nancy Van Prooyen ’03 investigates how the leukemia virus hijacks T-cells, which play a critical role in the immune system.
Jonathan Rupp ’04 studies the host factors involved in the viral RNA synthesis of influenza at the University of Alaska.
Mike Hoppa ’04 investigates the mechanisms of neutrotransmission and how they malfunction in seizures, schizophrenia, and autism at the Weill Cornell Medical College.
University of Washington researcher Anna Groat-Carmona ’06 investigates how HIV hoodwinks host proteins to chaperone its own replication.
David Rasmussen ’07 is researching the evolution of the Dengue virus and other RNA viruses as a population biologist at Duke.
Melissa Zarr ’08 is investigating combination antiretroviral therapies for HIV at Johns Hopkins.
Jeannette Tenthorey ’09 is studying how organisms sense the presence of pathogenic bacteria at UC Berkeley.
My Linh Nguyen ’09 works on obesity and feeding regulation at Oregon Health and Science University.